Rapid reconstitution packages (RRPs) for stable storage and delivery of glucagon

Current emergency injectors of glucagon require manual reconstitution, which involves several steps that may lead to dosage errors. Rapid reconstitution packages (RRPs) are new devices, designed using computational fluid dynamics (CFD) to optimize fluid mixing, integrating physical properties of active pharmaceutical ingredients (APIs), excipients and diluents. RRPs improve drug stability for long-term storage and ease of delivery. Device prototypes were manufactured using advanced stereolithography apparatus (SLA) 3D printing technology. Reconstitution of glucagon with RRPs was evaluated by high-performance liquid chromatography (HPLC) and optical spectroscopy methods. Enzyme-linked immunosorbent assays were performed to test in vitro activity. Experimental results showed that RRPs effectively reconstituted glucagon even after exposure to 60 °C for a 24-h period. RRPs exhibited improved performance at maintaining drug stability compared to lyophilized glucagon stored in a standard glass vial under the same temperature conditions. RRPs represent a portable platform for rapid reconstitution of lyophilized drugs, compatible with standard syringes available in any clinical setting. The RRP provides an alternative to manual reconstitution process, especially designed for medical emergencies.

[1]  Z. Xm,et al.  A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting , 2018, Yearbook of Paediatric Endocrinology.

[2]  Michael J Akers,et al.  Practical fundamentals of glass, rubber, and plastic sterile packaging systems , 2010, Pharmaceutical development and technology.

[3]  M. Haymond,et al.  Minimizing Morbidity of Hypoglycemia in Diabetes , 2014, Journal of diabetes science and technology.

[4]  R. Beck,et al.  Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes , 2016, Diabetes Care.

[5]  Nitil Kedia.  Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.

[6]  Teresa To,et al.  Systematic evaluation of errors occurring during the preparation of intravenous medication , 2008, Canadian Medical Association Journal.

[7]  S. Amiel,et al.  Hypoglycaemia in Type 2 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[8]  E. Seaquist,et al.  Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting , 2018, Diabetes, obesity & metabolism.

[9]  A. Pontiroli.  Intranasal Glucagon , 2014, Journal of diabetes science and technology.

[10]  D. Menon,et al.  Variability in the concentrations of intravenous drug infusions prepared in a critical care unit , 2008, Intensive Care Medicine.

[11]  A. Pontiroli,et al.  Intranasal Drug Delivery , 1989, Clinical pharmacokinetics.

[12]  J. Aronson,et al.  Medication errors: what they are, how they happen, and how to avoid them. , 2009, QJM : monthly journal of the Association of Physicians.

[13]  F. Wappler,et al.  Medication errors in pediatric emergencies: a systematic analysis. , 2012, Deutsches Arzteblatt international.

[14]  A. Merry,et al.  Medication errors – new approaches to prevention , 2011, Paediatric anaesthesia.

[15]  F. Reno,et al.  A novel nasal powder formulation of glucagon: toxicology studies in animal models , 2015, BMC Pharmacology and Toxicology.

[16]  A. Pontiroli,et al.  Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality? , 2018, Diabetes, obesity & metabolism.

[17]  P. Cryer.  Hierarchy of Physiological Responses to Hypoglycemia: Relevance to Clinical Hypoglycemia in Type I (Insulin Dependent) Diabetes Mellitus* , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  Shahrul Mt-Isa,et al.  Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis , 2010, Quality and Safety in Health Care.

[19]  E. Mohammadi,et al.  Factors Associated with Needlestick Injuries in Health Care Occupations: A Systematic Review. , 2016, Journal of clinical and diagnostic research : JCDR.

[20]  Sebastian Curi,et al.  Rapid Reconstitution Packages (RRPs) implemented by integration of computational fluid dynamics (CFD) and 3D printed microfluidics , 2014, Drug Delivery and Translational Research.

[21]  B. Larijani,et al.  The importance of hypoglycemia in diabetic patients , 2012, Journal of Diabetes & Metabolic Disorders.

[22]  P. Cryer,et al.  Hypoglycemia in diabetes. , 2003, Diabetes care.